よむ、つかう、まなぶ。
総－５参考３－１［643KB］ (2 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_53715.html |
| 出典情報 | 中央社会保険医療協議会 総会（第605回 3／12）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Kolbeck KR, Kozhich A, Koike ML, et a1. MEDI-563, a humanized anti-IL-5 receptor gmAb with
enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol.
2010:125(6):1844-1853.e2.
Pham 本日, Damera G, Newbold P Ranade 氏. Reductions in eosinophil biomarkers by
benrahzumab in patients with asthma. Respir Med. 2016: 111:21-29.
Clicallmials.gov ffcacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
(MLANDARAY*
httpng祖slimienltrim 司jgmvjstuttwyNCTU417計8
AstraZeneca press*Yelease “Fasenra approved in the US for selfadministration in a new pre・
filed auto-injector, the Fasenra Pen"
https:/がwww.astrazeneca.com/media-centre/iressYeleases/2019/fasenra-ammnrovedin・the-us-for
mElTFadlmirisllation-in・a-new-gre-filled-auto-injector-the-fasmermTU4102019.html
AstraZeneca press-release “Fasenra receves positive U CHMP opinion for selfadministration
and the new Fasenra pen, a pre-flled, single-use auto-injector"
htlns/www.astrazeneca.com/mmedia-centre/mressrelemsgs/211包Hagsmnra-recelves*HHOs1tive-eu・
hmnrnBtnion・for-self-administration-and-the-new-fasemnys*B@n*a-Hre illed・singlruserautnn・
Imtpml1U72019.html
Barker P Ferguson GT Cole J, et al. Single・use autoinjector functionality and rehabihty for at-
home benrahzumab admnnistratiom: GRECO trial results. J Allergy CHn Immunol1. 2019:143 (②)
SuDDlerment, page AB96
IMartin U, Fuhr R. Forte F, et al. Comparison of accessorized pre-illed syringe with autoinjector
for benralizumab pharmacokinetic exposure in healthy volunteers following administration of a
single subcutaneous dose: AMES trial results. J Allergy Chn Immunol. 2019:143 (⑫)
SuDDlement, page AB95.
enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol.
2010:125(6):1844-1853.e2.
Pham 本日, Damera G, Newbold P Ranade 氏. Reductions in eosinophil biomarkers by
benrahzumab in patients with asthma. Respir Med. 2016: 111:21-29.
Clicallmials.gov ffcacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
(MLANDARAY*
httpng祖slimienltrim 司jgmvjstuttwyNCTU417計8
AstraZeneca press*Yelease “Fasenra approved in the US for selfadministration in a new pre・
filed auto-injector, the Fasenra Pen"
https:/がwww.astrazeneca.com/media-centre/iressYeleases/2019/fasenra-ammnrovedin・the-us-for
mElTFadlmirisllation-in・a-new-gre-filled-auto-injector-the-fasmermTU4102019.html
AstraZeneca press-release “Fasenra receves positive U CHMP opinion for selfadministration
and the new Fasenra pen, a pre-flled, single-use auto-injector"
htlns/www.astrazeneca.com/mmedia-centre/mressrelemsgs/211包Hagsmnra-recelves*HHOs1tive-eu・
hmnrnBtnion・for-self-administration-and-the-new-fasemnys*B@n*a-Hre illed・singlruserautnn・
Imtpml1U72019.html
Barker P Ferguson GT Cole J, et al. Single・use autoinjector functionality and rehabihty for at-
home benrahzumab admnnistratiom: GRECO trial results. J Allergy CHn Immunol1. 2019:143 (②)
SuDDlerment, page AB96
IMartin U, Fuhr R. Forte F, et al. Comparison of accessorized pre-illed syringe with autoinjector
for benralizumab pharmacokinetic exposure in healthy volunteers following administration of a
single subcutaneous dose: AMES trial results. J Allergy Chn Immunol. 2019:143 (⑫)
SuDDlement, page AB95.